Saffron Medicare Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -76.99%
- Profit Growth -94.56%
- Ebitda -99.61%
- Net Worth -7.82%
- Total Assets -7.32%
About Saffron Medicare
Saffron Medicare Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 December 2008 and has a history of 16 years and two months. Its registered office is in Kurukshetra, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Inder Singh and Sharandeep Kaur serve as directors at the Company.
Company Details
-
Location
Kurukshetra, Haryana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232HR2008PTC038603
-
Company No.
038603
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Dec 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Saffron Medicare Private Limited offer?
Saffron Medicare Private Limited offers a wide range of products and services, including Pharma Franchise, PCD Pharma Franchise, Diclofenac, Diclofenac Sodium Injection, Antibacterial Drugs, Ofloxacin Ornidazole Tablets, Pantoprazole Drugs, Pantoprazole Tablets, Allopathic PCD Pharma Franchise, Ayurvedic Herbal Syrups & Tonics.
Who are the key members and board of directors at Saffron Medicare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Inder Singh
|
Managing Director | 12-Dec-2008 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sharandeep Kaur
|
Director | 30-Jul-2010 | Current |
Financial Performance of Saffron Medicare.
Saffron Medicare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 76.99% decrease. The company also saw a substantial fall in profitability, with a 94.56% decrease in profit. The company's net worth dipped by a decrease of 7.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saffron Medicare?
In 2020, Saffron Medicare had a promoter holding of 70.00% and a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Orange Biotech Private LimitedInder Singh and Sharandeep Kaur are mutual person
-
Curasia Medilabs Private LimitedInder Singh is a mutual person
-
Bioversal Remedies Private LimitedInder Singh is a mutual person
-
Biostem Pharma Private Limited
Inder Singh is a mutual person
-
Bioraiz Healthcare Private Limited
Inder Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Saffron Medicare?
Unlock and access historical data on people associated with Saffron Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saffron Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saffron Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
